Could a sleep pill curb alcohol cravings? new trial investigates

NCT ID NCT07214207

Recruiting now Disease control Sponsor: Ohio State University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether suvorexant, a sleep medication, can help people with alcohol use disorder drink less and handle stress better. About 250 adults who want to cut back on alcohol will take either the drug or a placebo nightly for 8 weeks. Researchers will track drinking habits, cravings, and stress responses through lab visits and daily smartphone reports.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Suvorexant (Belsomra), a sleep medication
What this could lead to: If it works, this could point toward a new treatment option for alcohol use disorder that also helps with stress-related drinking.
What could go wrong: This is a mid-stage trial with 250 people, so results are not yet proven. The drug may not reduce drinking more than a placebo, and side effects like daytime sleepiness are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

alcohol abuse

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALCOHOL USE DISORDER

Contacts and locations

Locations

Ohio State University
RECRUITING

Columbus, Ohio, 43210, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.